Blood tests could pave the way for distinguishing between Alzheimer’s, Parkinson’s and some dementias, aiding early treatment for brain diseases.

Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...

The partnership will initially focus on low-abundance biomarkers supporting translational research in Alzheimer's disease.

Scientists challenging conventional beliefs around the genetic risk factors for Alzheimer’s have discovered a genetic link ...

Acumen and JCR aim to develop a product leveraging Acumen's amyloid beta oligomer-selective antibody expertise and JCR's transferrin-receptor-targeting blood-brain barrier-penetrating technologyPrecli ...

Eli Lilly and Company (NYSE: LLY) is one of Goldman Sachs’ top healthcare stock picks. On July 9, the company confirmed the ...

The Mirror's former editor Alison Phillips has spoken to ITV's Lorraine Kelly about her friend Fiona Phillips, giving an update on her experience with Alzheimer's ...

Robert Johnson was last seen on Monday night at an apartment complex on Trinity Place, and police are hoping someone knows ...

Connecticut joins more than 20 states mandating insurance coverage cover biomarker tests, said Christy Kovel, director of ...

DAYTON — The Alzheimer’s Association Northwest Ohio Chapter is hosting several free programs in July. Register for these and ...

Massive proteomics database links gene variant APOE 4 to chronic inflammation.

New research shows that signs of Alzheimer’s disease can already be detected in the blood of people as young as their 40s.